SRS Capital Advisors »

Theravance Biopharma shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $460 57 8.07
2024-06-30 $483 57 8.49

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Schwab Strategic Tr Us Tips Etf (SCHP)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Apple (AAPL)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
State Street Corporation
Oasis Management
Camber Capital Management
Geode Capital Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Dimensional Fund Advisors
Nuveen Asset Management

View all funds holding Theravance Biopharma